Breaking News Instant updates and real-time market news.

KMPH

KemPharm

$2.16

0.06 (2.86%)

16:17
10/30/18
10/30
16:17
10/30/18
16:17

KemPharm enters into licensing agreement with KVK Tech for Apadaz

KemPharm announced its entry into a definitive collaboration and license agreement with KVK Tech for the U.S. commercial rights of its FDA-approved prodrug product, Apadaz Under the terms of the agreement, KemPharm is eligible to receive up to an estimated $3.4M in pre-launch payments and certain cost reimbursements, including a $2.0M payment upon achievement of a specified milestone related to the initial formulary adoption of Apadaz, as well as an aggregate of up to $53M in milestone payments tied to specific net sales levels. In addition, net profits will be shared between KemPharm and KVK up to 50% based on achieving specified net sales levels. KVK has the exclusive right for all commercial, manufacturing, packaging and distribution activities for Apadaz in the U.S. and will be responsible for all regulatory and commercialization-related expenses. In addition, certain pre-launch expenses, including the costs of API and other materials for manufacturing, validation batches, inventory investments and other launch-specific costs will be shifted from KemPharm to KVK. Pre-launch activities that KemPharm and KVK will continue to collaborate on include outreach and plan adoption by pharmacy benefit managers and managed care organizations for the exclusive utilization of Apadaz as an alternative to currently available hydrocodone/acetaminophen products.

KMPH KemPharm
$2.16

0.06 (2.86%)

09/20/18
OPCO
09/20/18
INITIATION
OPCO
Outperform
KemPharm assumed with an Outperform at Oppenheimer
Oppenheimer analyst Esther Rajavelu assumed coverage of KemPharm with an Outperform rating and an $11 price target, primarily due to a change in the firm's valuation methodology.
07/09/18
COWN
07/09/18
DOWNGRADE
COWN
Market Perform
KemPharm downgraded to Market Perform from Outperform at Cowen
Cowen analyst Ken Cacciatore downgraded KemPharm to Market Perform from Outperform citing uncertainty on the path forward for KP415 after the company announced top line results from a pivotal efficacy and safety clinical trial of the investigational attention-deficit/hyperactivity disorder product candidate.
05/23/18
JANY
05/23/18
INITIATION
Target $17
JANY
Buy
KemPharm initiated with a Buy at Janney Capital
Janney Capital analyst Ken Trbovich initiated KemPharm with a Buy rating and $17 fair value estimate.
02/26/18
ADAM
02/26/18
NO CHANGE
Target $11
ADAM
Buy
KemPharm price target raised to $11 from $7 at Canaccord
Canaccord analyst Dewey Steadman raised his price target on KemPharm to $11 from $7 citing the FDA approval of Apadaz as a clear positive and a validation of the company's prodrug technology platform. He believes the company's strategy to position Apadaz as a generic to take advantage of the current market environment is a smart move. Steadman reiterated his Buy rating on KemPharm shares.

TODAY'S FREE FLY STORIES

09:30
08/22/19
08/22
09:30
08/22/19
09:30
General news
PMI Composite FLASH Manufacturing â€' Level to be reported at 09:45 »

August PMI Composite…

09:30
08/22/19
08/22
09:30
08/22/19
09:30
General news
PMI Composite FLASH â€' Level to be reported at 09:45 »

August PMI Composite…

VWAGY

Volkswagen

$0.00

(0.00%)

, TSLA

Tesla

$220.89

-4.81 (-2.13%)

09:29
08/22/19
08/22
09:29
08/22/19
09:29
Periodicals
Volkswagen seeks to take stake in Tesla, Reuters reports »

Herbert Diess, the CEO of…

VWAGY

Volkswagen

$0.00

(0.00%)

TSLA

Tesla

$220.89

-4.81 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 23

    Sep

SMPL

Simply Good Foods

$27.35

0.55 (2.05%)

09:28
08/22/19
08/22
09:28
08/22/19
09:28
Recommendations
Simply Good Foods analyst commentary  »

Simply Good Foods price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPLD

Upland Software

$42.75

0.38 (0.90%)

09:27
08/22/19
08/22
09:27
08/22/19
09:27
Earnings
Upland Software raises FY19 revenue view to $212.3M-$216.3M from $209.9M-$213.9M »

Consensus $212.42M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPLD

Upland Software

$42.75

0.38 (0.90%)

09:25
08/22/19
08/22
09:25
08/22/19
09:25
Earnings
Upland Software raises Q3 revenue view to $54.1M-$56.1M from $53.5M-$55.5M »

Consensus $56.16M. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
08/22/19
08/22
09:25
08/22/19
09:25
Conference/Events
JPMorgan alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy/IT…

09:25
08/22/19
08/22
09:25
08/22/19
09:25
Conference/Events
UBS basic materials analyst to hold an analyst/industry conference call »

Basic Materials Analyst…

WORK

Slack Technologies

$30.81

0.315 (1.03%)

09:24
08/22/19
08/22
09:24
08/22/19
09:24
Initiation
Slack Technologies initiated  »

Slack Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

SMAR

Smartsheet

$52.20

1.015 (1.98%)

09:24
08/22/19
08/22
09:24
08/22/19
09:24
Initiation
Smartsheet initiated  »

Smartsheet assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

ZM

Zoom Video

$92.84

1.49 (1.63%)

09:23
08/22/19
08/22
09:23
08/22/19
09:23
Initiation
Zoom Video initiated  »

Zoom Video assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

PEGI

Pattern Energy

$25.83

0.23 (0.90%)

, BAM

Brookfield

$51.95

0.445 (0.86%)

09:23
08/22/19
08/22
09:23
08/22/19
09:23
Recommendations
Pattern Energy, Brookfield analyst commentary  »

Pattern Energy price…

PEGI

Pattern Energy

$25.83

0.23 (0.90%)

BAM

Brookfield

$51.95

0.445 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

WCC

Wesco

$43.29

-0.12 (-0.28%)

09:22
08/22/19
08/22
09:22
08/22/19
09:22
Upgrade
Wesco rating change  »

Wesco upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

  • 16

    Sep

  • 13

    Nov

LOGM

LogMeln

$69.64

0.63 (0.91%)

09:22
08/22/19
08/22
09:22
08/22/19
09:22
Initiation
LogMeln initiated  »

LogMeln assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPLD

Upland Software

$42.75

0.38 (0.90%)

09:20
08/22/19
08/22
09:20
08/22/19
09:20
Hot Stocks
Upland Software acquires Cimpl for $23.1M in cash »

Upland Software has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIFY

Sify Technologies

$1.28

(0.00%)

09:19
08/22/19
08/22
09:19
08/22/19
09:19
Hot Stocks
Sify Technologies partners with ZSAH to extend consulting practice into Europe »

Sify Technologies Limited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
08/22/19
08/22
09:18
08/22/19
09:18
Options
Overnight activity included 448 trades in SPX and 9 trades in VIX »

448 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBIO

Pressure BioSciences

$0.00

(0.00%)

09:17
08/22/19
08/22
09:17
08/22/19
09:17
Hot Stocks
Pressure BioSciences announces two purchase orders for BaroShear K45 system »

Pressure BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOB

Live Oak Bancshares

$18.15

0.03 (0.17%)

09:17
08/22/19
08/22
09:17
08/22/19
09:17
Conference/Events
Live Oak Bancshares management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

CORR

CorEnergy

$45.85

0.95 (2.12%)

09:17
08/22/19
08/22
09:17
08/22/19
09:17
Hot Stocks
CorEnergy announces FERC approval of MoGas rate case »

CorEnergy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNV

Synovus

$35.54

0.36 (1.02%)

09:16
08/22/19
08/22
09:16
08/22/19
09:16
Conference/Events
Synovus management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 29

    Aug

  • 23

    Sep

BDRBF

Bombardier

$0.00

(0.00%)

09:16
08/22/19
08/22
09:16
08/22/19
09:16
Hot Stocks
Bombardier wins contract to supply, maintain 30 FLEXITY trams in Dresden »

Bombardier Transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNO

Terreno Realty

$50.49

-0.03 (-0.06%)

09:15
08/22/19
08/22
09:15
08/22/19
09:15
Hot Stocks
Terreno Realty acquires property in Auburn, WA for $9.5M »

Terreno Realty acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNV

Synovus

$35.54

0.36 (1.02%)

09:15
08/22/19
08/22
09:15
08/22/19
09:15
Conference/Events
Synovus management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 29

    Aug

  • 23

    Sep

VVI

Viad

$67.02

0.99 (1.50%)

09:14
08/22/19
08/22
09:14
08/22/19
09:14
Conference/Events
Viad management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.